Comprehensive evaluation and validation of targeted next generation sequencing performance in two clinical laboratories

International Journal of Oncology

Volumn 49, Issue 1, 2016, Pages 235-242

  Mendez, Pedro ^a,b   Dang, Jennifer ^c   Kim, James Wansoo ^c   Lee, Sharon ^c   Yoon, Jun Hee ^a,b   Kim, Thomas ^c   Sailey, Charles J ^c,d   Jablons, David M ^a,b   Kim, Il Jin ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CureSeq Inc   (United States)

^d Purity Laboratories   (United States)

Author keywords

Cancer; Clinical laboratory; Diagnosis; Mutation; Next generation sequencing

Indexed keywords

ACCURACY; ARTICLE; CLINICAL LABORATORY; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; LIMIT OF DETECTION; NEXT GENERATION SEQUENCING; ONCOGENE K RAS; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REPRODUCIBILITY; SEQUENCE ALIGNMENT; SOMATIC MUTATION; GENETIC SCREENING; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MOLECULAR PATHOLOGY; MUTATION; NEOPLASMS; PROCEDURES; STANDARDS; TISSUE FIXATION;

PARAFFIN;

GENETIC TESTING; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NEOPLASMS; PARAFFIN EMBEDDING; PATHOLOGY, MOLECULAR; TISSUE FIXATION;

EID: 84978434544     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3497     Document Type: Article

References (28)

1. Cancer Genome Atlas Research Network: Comprehensive molecular profiling of lung adenocarcinoma. Nature 511: 543-550, 2014.
2. George J, Lim JS, Jang SJ, Cun Y, Ozreti L, Kong G, Leenders F, Lu X, Fernández-Cuesta L, Bosco G, et al: Comprehensive genomic profiles of small cell lung cancer. Nature 524: 47-53, 2015.
3. Govindan R, Ding L, Griffith M, Subramanian J, Dees ND, Kanchi KL, Maher CA, Fulton R, Fulton L, Wallis J, et al: Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150: 1121-1134, 2012.
4. Hammerman PS, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, et al; Cancer Genome Atlas Research Network: Comprehensive genomic characterization of squamous cell lung cancers. Nature 489: 519-525, 2012.
5. Network TCGA; Cancer Genome Atlas Network: Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337, 2012.
6. Cancer Genome Atlas Network: Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70, 2012.
7. Abstract G and Brief I; Cancer Genome Atlas Research Network: The Molecular Taxonomy of Primary Prostate Cancer. Cell 163: 1011-1025, 2015.
8. Cancer Genome Atlas Research Network: Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507: 315-322, 2014.
9. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, et al: A landscape of driver mutations in melanoma. Cell 150: 251-263, 2012.
10. Bass AJ, Thorsson V, Shmulevich I, Reynolds SM, Miller M, Bernard B, Hinoue T, Laird PW, Curtis C, Shen H, Weisenberger DJ, et al; Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513: 202-209, 2014.
11. Andersson AK, Ma J, Wang J, Chen X, Gedman AL, Dang J, Nakitandwe J, Holmfeldt L, Parker M, Easton J, et al; St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project: The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet 47: 330-337, 2015.
12. Brennan CWW, Verhaak RGWGW, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, et al; TCGA Research Network: The somatic genomic landscape of glioblastoma. Cell 155: 462-477, 2013.
13. Cancer Genome Atlas Research Network: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 368: 2059-2074, 2013.
14. Cancer T and Atlas G; Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615, 2011.
15. Chan-On W, Nairismägi M-L, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, et al: Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 45: 1474-1478, 2013.
16. Chen K, Yang D, Li X, Sun B, Song F, Cao W, Brat DJ, Gao Z, Li H, Liang H, et al: Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy. Proc Natl Acad Sci USA 112: 1107-1112, 2015.
17. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, et al: Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343: 189-193, 2014.
18. Jones DTW, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, et al: Dissecting the genomic complexity underlying medulloblastoma. Nature 488: 100-105, 2012.
19. Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, Getz G, Ally A, Balasundaram M, Birol I, et al; Cancer Genome Atlas Network: Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517: 576-582, 2015.
20. Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, et al: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet 46: 872-876, 2014.
21. Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, et al: Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet 46: 467-473, 2014.
22. Lohr JG, Stojanov P, Carter SL, Cruz-Gordillo P, Lawrence MS, Auclair D, Sougnez C, Knoechel B, Gould J, Saksena G, et al; Multiple Myeloma Research Consortium: Widespread genetic heterogeneity in multiple myeloma: Implications for targeted therapy. Cancer Cell 25: 91-101, 2014.
23. Creighton CJ, Morgan M, Gunaratne PH, Wheeler DA, Gibbs RA, Gordon Robertson A, Chu A, Beroukhim R, Cibulskis K, Signoretti S, et al; Cancer Genome Atlas Research Network: Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499: 43-49, 2013.
24. Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetête-Lalami S, Rusch M, et al; St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the International Cancer Genome Consortium: Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 4: 1342-1353, 2014.
25. Carrick DM, Mehaffey MG, Sachs MC, Altekruse S, Camalier C, Chuaqui R, Cozen W, Das B, Hernandez BY, Lih CJ, et al: Robustness of next generation sequencing on older formalinfixed paraffin-embedded tissue. PLoS One 10: e0127353, 2015.
26. Fujita S, Masago K, Takeshita J, Okuda C, Otsuka K, Hata A, Kaji R, Katakami N and Hirata Y: Validation of an ion torrent sequencing platform for the detection of gene mutations in biopsy specimens from patients with non-small-cell lung cancer. PLoS One 10: e0130219, 2015.
27. Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, et al: An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20: 548-554, 2014.
28. Dawson SJ, Tsui DWY, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, et al: Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368: 1199-1209, 2013.